Biosimilars 101: The Science, Approval Process, and Implications for Your Practice

by Steven Lucio, Ali McBride

Overview

Since their emergence in the early 1980s, biologic drugs have been increasingly viewed as the future of medicine. Biosimilars are “follow-on” reproductions of these complex molecules. By 2015, more than 30 branded biologics are expected to lose patent exclusivity, while the pool of biosimilars is expected to grow more than 20% per year.
Now that the US Food and Drug Administration (FDA) has authority to approve biosimilars, they are expected to enter the US market within the next 1 to 2 years. This supplement is intended to increase your understanding of the biosimilar development and approval process, the interchangeability of biosimilars with reference products, and the steps required to evaluate these new products for addition to formularies.

Product Details

BN ID:	2940149594214
Publisher:	Hospital Pharmacy
Publication date:	03/06/2014
Sold by:	Barnes & Noble
Format:	eBook
File size:	1 MB